60 related articles for article (PubMed ID: 2116222)
1. Expression of a resistance mechanism in ovarian and cervical carcinoma cells prevents their lysis by gamma-interferon.
Massad LS; Mutch DG; Powell CB; Kao MS; Collins JL
Cancer Res; 1990 Aug; 50(16):4923-8. PubMed ID: 2116222
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of protein synthesis enhances the lytic effects of tumor necrosis factor alpha and interferon gamma in cell lines derived from gynecological malignancies.
Massad LS; Mutch DG; Kao MS; Powell CB; Collins JL
Cancer Immunol Immunother; 1991; 33(3):183-8. PubMed ID: 1904315
[TBL] [Abstract][Full Text] [Related]
3. Interferon alfa activates a lytic mechanism in ovarian and cervical carcinoma cells.
Powell CB; Horuchi T; Kao MS; Collins JL
Am J Obstet Gynecol; 1993 Sep; 169(3):661-7. PubMed ID: 8372877
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the protein synthesis independent TNFalpha lytic mechanism in human ovarian and cervical carcinoma cell lines.
Powell CB; Scott JH; Collins JL
Gynecol Oncol; 1996 Jul; 62(1):42-8. PubMed ID: 8690290
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo.
Sayers TJ; Wiltrout TA; McCormick K; Husted C; Wiltrout RH
Cancer Res; 1990 Sep; 50(17):5414-20. PubMed ID: 2117482
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of interferon induction of class I major histocompatibility complex antigen expression by human tumor necrosis factor in small cell lung cancer cell lines.
Marley GM; Doyle LA; Ordóñez JV; Sisk A; Hussain A; Yen RW
Cancer Res; 1989 Nov; 49(22):6232-6. PubMed ID: 2553249
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma and tumor necrosis factor-alpha induce synergistic cytolytic effects in ovarian cancer cell lines-roles of the TR60 and TR80 tumor necrosis factor receptors.
Kost ER; Mutch DG; Herzog TJ
Gynecol Oncol; 1999 Mar; 72(3):392-401. PubMed ID: 10053112
[TBL] [Abstract][Full Text] [Related]
8. Comparison of TNFalpha and TNFbeta cytolytic mechanisms in human ovarian and cervical carcinoma cell lines.
Powell CB; Scott JH; Collins JL
Gynecol Oncol; 1998 Nov; 71(2):258-65. PubMed ID: 9826469
[TBL] [Abstract][Full Text] [Related]
9. Modulation of interferon receptor expression during combination beta ser-interferon and gamma-interferon treatment of human colon carcinoma cells.
Schiller JH; Bushmeyer SM; Ruzicka FJ; Princler GL; Faltynek CR; Borden EC
Cancer Res; 1990 Jan; 50(1):26-31. PubMed ID: 2136700
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor cell growth by interferon-gamma is mediated by two distinct mechanisms dependent upon oxygen tension: induction of tryptophan degradation and depletion of intracellular nicotinamide adenine dinucleotide.
Aune TM; Pogue SL
J Clin Invest; 1989 Sep; 84(3):863-75. PubMed ID: 2503544
[TBL] [Abstract][Full Text] [Related]
11. Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters.
Leon JA; Mesa-Tejada R; Gutierrez MC; Estabrook A; Greiner JW; Schlom J; Fisher PB
Anticancer Res; 1989; 9(6):1639-47. PubMed ID: 2516715
[TBL] [Abstract][Full Text] [Related]
12. Effects of biological response modifiers on ovarian carcinoma cell lines.
Marth C; Helmberg M; Mayer I; Fuith LC; Daxenbichler G; Dapunt O
Anticancer Res; 1989; 9(2):461-7. PubMed ID: 2502063
[TBL] [Abstract][Full Text] [Related]
13. [Anti-proliferative effects of tumor necrosis factor and gamma interferon on human ovarian cancer cell lines].
Li J; Liu YL; Sha JY
Zhonghua Fu Chan Ke Za Zhi; 1994 Nov; 29(11):670-2, 700. PubMed ID: 7712890
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1.
Morikawa K; Fidler IJ
J Biol Response Mod; 1989 Apr; 8(2):206-18. PubMed ID: 2499665
[TBL] [Abstract][Full Text] [Related]
15. New combination of 5-fluorouracil and interferon-gamma effective against human myeloid leukemia in vitro.
Kafka M; Nathan I; Dvilansky A
Anticancer Res; 1989; 9(4):1037-40. PubMed ID: 2510579
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of a human colorectal carcinoma cell line by interleukin 1 is associated with enhanced expression of gamma-interferon receptors.
Raitano AB; Korc M
Cancer Res; 1993 Feb; 53(3):636-40. PubMed ID: 8425199
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma induces apoptosis in ovarian cancer cells in vivo and in vitro.
Wall L; Burke F; Barton C; Smyth J; Balkwill F
Clin Cancer Res; 2003 Jul; 9(7):2487-96. PubMed ID: 12855622
[TBL] [Abstract][Full Text] [Related]
19. Synergistic antitumor effects of tumor necrosis factor and gamma-interferon on human colon carcinoma cell lines.
Schiller JH; Bittner G; Storer B; Willson JK
Cancer Res; 1987 Jun; 47(11):2809-13. PubMed ID: 3105867
[TBL] [Abstract][Full Text] [Related]
20. Cytokines alter target cell susceptibility to lysis. II. Evaluation of tumor infiltrating lymphocytes.
Stötter H; Wiebke EA; Tomita S; Belldegrun A; Topalian S; Rosenberg SA; Lotze MT
J Immunol; 1989 Mar; 142(5):1767-73. PubMed ID: 2493053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
